5-Nov-2025 8:30 AM CST - Yahoo Finance Is Now The Time To Put ResMed (NYSE:RMD) On Your Watchlist? In contrast to all that, many investors prefer to focus on companies like ResMed (NYSE:RMD), which has not only revenues, but also profits. Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide ResMed with the means to add long-term value to shareholders.
31-Oct-2025 8:24 AM CST - Benzinga These Analysts Revise Their Forecasts On ResMed Following Q1 Results ResMed Inc. (NYSE: RMD) reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.50 per share. The company reported quarterly sales of $1.336 billion which beat the analyst consensus estimate of $1.331 billion.
31-Oct-2025 7:35 AM CST - Yahoo Finance Is It Time To Consider Buying ResMed Inc. (NYSE:RMD)? Let's talk about the popular ResMed Inc. . The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to U
30-Oct-2025 3:30 PM CST - Yahoo Finance ResMed: Fiscal Q1 Earnings Snapshot ResMed Inc. RMD) on Thursday reported fiscal first-quarter net income of $348.5 million. On a per-share basis, the San Diego-based company said it had net income of $2.37.
29-Oct-2025 4:35 PM CST - Seeking Alpha ResMed Q1 2026 Earnings Preview ResMed (RMD) is scheduled to announce Q1 earnings results on Thursday, October 30th, after market close. The consensus EPS Estimate is $2.50 (+13.6% Y/Y) and th
29-Oct-2025 11:01 AM CST - Benzinga Insights into ResMed's Upcoming Earnings The market awaits ResMed's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to u
Latest RMD Trades by Congress Members
4-JUN-2025 - Kelly Louise Morrison, MN (District 3) sold between $1,001 and $15,000.
5-Nov-2025 8:30 AM CST - Yahoo Finance Is Now The Time To Put ResMed (NYSE:RMD) On Your Watchlist? In contrast to all that, many investors prefer to focus on companies like ResMed (NYSE:RMD), which has not only revenues, but also profits. Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide ResMed with the means to add long-term value to shareholders.
31-Oct-2025 8:24 AM CST - Benzinga These Analysts Revise Their Forecasts On ResMed Following Q1 Results ResMed Inc. (NYSE: RMD) reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.50 per share. The company reported quarterly sales of $1.336 billion which beat the analyst consensus estimate of $1.331 billion.
31-Oct-2025 7:35 AM CST - Yahoo Finance Is It Time To Consider Buying ResMed Inc. (NYSE:RMD)? Let's talk about the popular ResMed Inc. . The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to U
30-Oct-2025 3:30 PM CST - Yahoo Finance ResMed: Fiscal Q1 Earnings Snapshot ResMed Inc. RMD) on Thursday reported fiscal first-quarter net income of $348.5 million. On a per-share basis, the San Diego-based company said it had net income of $2.37.
29-Oct-2025 4:35 PM CST - Seeking Alpha ResMed Q1 2026 Earnings Preview ResMed (RMD) is scheduled to announce Q1 earnings results on Thursday, October 30th, after market close. The consensus EPS Estimate is $2.50 (+13.6% Y/Y) and th
29-Oct-2025 11:01 AM CST - Benzinga Insights into ResMed's Upcoming Earnings The market awaits ResMed's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to u
